A study has confirmed that MAL serves as a bridge between TLR2/TLR4- and MyD88-mediated signaling to orchestrate downstream inflammatory responses and regulate intestinal homeostasis and colitis-associated colorectal cancer in mice [43]. The gene discussed is TLR2; the disease is colitis.